RxDoctor Payments Data

Vincent Accurso

Physician Assistant · Toms River, NJNPI 1316228067

Payments from drug & device makers

$4,989in general payments, 2019–2025

Across 286 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$909
  • Johnson & Johnson$551
  • Arcutis Biotherapeutics, Inc.$465
  • Sun Pharmaceutical Industries Inc.$425
  • Dermavant Sciences, Inc.$394
  • LEO Pharma Inc.$268
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$4,36888%
  • Education$62112%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,989 in reported general payments places this provider in the 90th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Medicare billing

Part B allowed, 2024
$218,390
Medicare patients
762
Services billed
3,959

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast18$80,522
Dupixent PenDupilumab15$52,561
Clobetasol Propionate123$5,113
Ketoconazole182$3,424
Metronidazole26$1,571
Mometasone Furoate69$1,570
Betamethasone Valerate34$929
Tacrolimus11$866
Triamcinolone Acetonide85$849
Doxycycline Hyclate49$828
Mupirocin89$574
Clindamycin Phosphate15$454
Betamethasone Dipropionate15$404
Hydroxyzine Hcl21$293
ValacyclovirValacyclovir Hcl15$292

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$34$80,52218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Toms River

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →